Fractionation of mouse bone-marrow cells limits functional efficacy in non-reperfused mouse model of acute myocardial infarction

References

• Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation. 2004;109:2692–7.
   PubMed Web of Science ®Google Scholar
• Rosenzweig A. Cardiac cell therapy—mixed results from mixed cells. N Engl J Med. 2006;355:1274–7.
   PubMed Web of Science ®Google Scholar
• Wollert KC, Drexler H. Clinical applications of stem cells for the heart. Circ Res. 2005;96:151–63.
   PubMed Web of Science ®Google Scholar
• Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, . Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation. 2002;106:3009–17.
   PubMed Web of Science ®Google Scholar
• Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, . Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364:141–8.
   PubMed Web of Science ®Google Scholar
• Fernandez-Aviles F, San Roman JA, Garcia-Frade J, Fernandez ME, Penarrubia MJ, de la Fuente L, . Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res. 2004;95:742–8.
   PubMed Web of Science ®Google Scholar
• Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, . Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210–21.
   PubMed Web of Science ®Google Scholar
• Hashemi SM, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D, . A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J. 2008;29:251–9.
   Google Scholar
• de Silva R, Raval AN, Hadi M, Gildea KM, Bonifacino AC, Yu ZX, . Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction. Eur Heart J. 2008;29:1772–82.
   Google Scholar
• Herbots L, D'hooge J, Eroglu E, Thijs D, Ganame J, Claus P, . Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study. Eur Heart J. 2009;30: 662–70.
   PubMed Web of Science ®Google Scholar
• Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res. 2006;98:1414–21.
   PubMed Web of Science ®Google Scholar
• Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, . Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006;20:661–9.
   PubMed Web of Science ®Google Scholar
• Yeghiazarians Y, Zhang Y, Prasad M, Shih H, Saini SA, Takagawa J, . Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy. Mol Ther. 2009;17:1250–6.
   PubMed Web of Science ®Google Scholar
• Assmus B, Tonn T, Seeger FH, Yoon CH, Leistner D, Klotsche J, . Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy. J Am Coll Cardiol. 2010;55:1385–94.
   Google Scholar
• Deindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G, . G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J. 2006;20:956–8.
   PubMed Web of Science ®Google Scholar
• Yeghiazarians Y, Khan M, Angeli FS, Zhang Y, Jahn S, Prasad M, . Cytokine combination therapy with long-acting erythropoietin and granulocyte colony stimulating factor improves cardiac function but is not superior than monotherapy in a mouse model of acute myocardial infarction. J Card Fail. 2010;16:669–78.
   PubMed Web of Science ®Google Scholar
• van der Bogt KE, Sheikh AY, Schrepfer S, Hoyt G, Cao F, Ransohoff KJ, . Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation. 2008;118:S121–9.
   PubMed Web of Science ®Google Scholar
• Springer ML, Sievers RE, Viswanathan MN, Yee MS, Foster E, Grossman W, . Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography. Am J Physiol Heart Circ Physiol. 2005;289:H1307–14.
   Web of Science ®Google Scholar
• Takagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, Wang Y, . Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol. 2007;102:2104–11.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Takagawa J, Sievers RE, Khan MF, Viswanathan MN, Springer ML, . Validation of the wall motion score and myocardial performance indexes as novel techniques to assess cardiac function in mice after myocardial infarction. Am J Physiol Heart Circ Physiol. 2007;292:H1187–92.
   Google Scholar
• Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, . Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J. 2006;27:2775–83.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sievers RE, Prasad M, Mirsky R, Shih H, Wong ML, . Timing of bone marrow cell therapy is more important than repeated injections after myocardial infarction. Cardiovasc Pathol. 2011;20:204–12.
   Google Scholar
• van Laake LW, Passier R, Doevendans PA, Mummery CL. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res. 2008;102:1008–10.
   PubMed Web of Science ®Google Scholar
• Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, . Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol. 2007;50:1884–93.
   PubMed Web of Science ®Google Scholar
• Sun J, Li SH, Liu SM, Wu J, Weisel RD, Zhuo YF, . Improvement in cardiac function after bone marrow cell therapy is associated with an increase in myocardial inflammation. Am J Physiol Heart Circ Physiol. 2009;296:H43–50.
   Google Scholar
• Kolpakov MA, Seqqat R, Rafiq K, Xi H, Margulies KB, Libonati JR, . Pleiotropic effects of neutrophils on myocyte apoptosis and left ventricular remodeling during early volume overload. J Mol Cell Cardiol. 2009;47:634–45.
   Google Scholar
• Swijnenburg RJ, Govaert JA, van der Bogt KE, Pearl JI, Huang M, Stein W, . Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction. Circ Cardiovasc Imaging. 2010;3:77–85.
   Google Scholar
• Liu F, Smith J, Zhang Z, Cole R, Herron BJ. Genetic heterogeneity of skin microvasculature. Dev Biol. 2010;340:480–9.
   Google Scholar
• Clark LD, Clark RK, Heber-Katz E. A new murine model for mammalian wound repair and regeneration. Clin Immunol Immunopathol. 1998;88:35–45.
   PubMedGoogle Scholar
• Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J. 2007;28:766–72.
   PubMed Web of Science ®Google Scholar
• Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, . Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355:1199–209.
   PubMed Web of Science ®Google Scholar
• Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, . Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004;109:1615–22.
   PubMed Web of Science ®Google Scholar
• Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol. 2005;45:1441–8.
   PubMed Web of Science ®Google Scholar
• Hill JM, Bartunek J. The end of granulocyte colony-stimulating factor in acute myocardial infarction? Reaping the benefits beyond cytokine mobilization. Circulation. 2006;113:1926–8.
   PubMed Web of Science ®Google Scholar
• Norol F, Bonnet N, Peinnequin A, Chretien F, Legrand R, Isnard R, . GFP-transduced CD34 and Lin- CD34- hematopoietic stem cells did not adopt a cardiac phenotype in a nonhuman primate model of myocardial infarct. Exp Hematol. 2007;35:653–61.
   Google Scholar
• Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, . Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007;167:989–97.
   PubMed Web of Science ®Google Scholar
• Reffelmann T, Kloner RA. Cellular cardiomyoplasty—cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res. 2003;58:358–68.
   Google Scholar
• Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, . Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;111:2198–202.
   PubMed Web of Science ®Google Scholar
• Sheikh AY, Lin SA, Cao F, Cao Y, van der Bogt KE, Chu P, . Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells. 2007;25:2677–84.
   PubMed Web of Science ®Google Scholar
• Cao F, Wagner RA, Wilson KD, Xie X, Fu JD, Drukker M, . Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS ONE. 2008;3:e3474.
   PubMed Web of Science ®Google Scholar
• Li Z, Lee A, Huang M, Chun H, Chung J, Chu P, . Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol. 2009;53:1229–40.
   PubMed Web of Science ®Google Scholar